Artificial pancreas effectively controls type 1 diabetes in children age 6 and up

A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system – which automatically monitors and regulates blood glucose levels – is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system – which automatically monitors and regulates blood glucose levels – is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Results from the trial were published August 26 in the New England Journal of Medicine.